Opioidergic: Difference between revisions
Content deleted Content added
m →Allosteric modulators: Task 7c: repair/replace et al. in cs1 author/editor parameters; |
→See also: removed links to questionable terms not supported by reliable sources |
||
| Line 18: | Line 18: | ||
* [[Dopaminergic]] |
* [[Dopaminergic]] |
||
* [[GABAergic]] |
* [[GABAergic]] |
||
* [[GHBergic]] |
|||
* [[Glycinergic]] |
* [[Glycinergic]] |
||
* [[Histaminergic]] |
* [[Histaminergic]] |
||
| Line 24: | Line 23: | ||
* [[Monoaminergic]] |
* [[Monoaminergic]] |
||
* [[Serotonergic]] |
* [[Serotonergic]] |
||
* [[Sigmaergic]] |
|||
==References== |
==References== |
||
Revision as of 10:50, 7 November 2015
An opioidergic agent (or drug) is a chemical which functions to directly modulate the opioid neuropeptide systems (i.e., endorphin, enkephalin, dynorphin, nociceptin) in the body or brain. Examples include opioid analgesics such as morphine and opioid antagonists such as naloxone. Opioidergics also comprise allosteric modulators and enzyme affecting agents like enkephalinase inhibitors.
Allosteric modulators
- BMS-986121: μ-PAM[1]
- BMS-986122: μ-PAM[1]
- δ-PAM (see reference)[2]
- Cannabidiol[3]
- Tetrahydrocannabinol[3]
- Sodium (Na+) [4]
See also
- Adenosinergic
- Adrenergic
- Cannabinoidergic
- Cholinergic
- Dopaminergic
- GABAergic
- Glycinergic
- Histaminergic
- Melatonergic
- Monoaminergic
- Serotonergic
References
- ^ a b Burford NT, Clark MJ, Wehrman TS, et al. (June 2013). "Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor". Proc. Natl. Acad. Sci. U.S.A. 110 (26): 10830–5. doi:10.1073/pnas.1300393110. PMC 3696790. PMID 23754417.
- ^ Burford NT, Livingston KE, Canals M, Ryan MR, Budenholzer LM, Han Y, Shang Y, Herbst JJ, O'Connell J, Banks M, Zhang L, Filizola M, Bassoni DL, Wehrman TS, Christopoulos A, Traynor JR, Gerritz SW, Alt A (2015). "Discovery, Synthesis, and Molecular Pharmacology of Selective Positive Allosteric Modulators of the δ-Opioid Receptor". J. Med. Chem. doi:10.1021/acs.jmedchem.5b00007. PMID 25901762.
- ^ a b Kathmann M, Flau K, Redmer A, Tränkle C, Schlicker E (February 2006). "Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors". Naunyn Schmiedebergs Arch. Pharmacol. 372 (5): 354–61. doi:10.1007/s00210-006-0033-x. PMID 16489449.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Shang Y, LeRouzic V, Schneider S, Bisignano P, Pasternak GW, Filizola M (2014). "Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions". Biochemistry. 53 (31): 5140–9. doi:10.1021/bi5006915. PMID 25073009.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |